Catalyst Wire Dossier Catalyst Wire Dossier

nevirapine-based regimen

nevirapine-based regimen
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for nevirapine-based regimen, covering 2021-03-17 to 2021-03-17. Get the full timeline:

Most recent: Clinical Trial Update: Switch From Nevirapine-based Regimen to Once a Day Rilpivirine/Emtricitabine/Tenofovir [Phase 2, Phase 3]

See pricing